Evaluation of Questionnaires of Tumor Patients With and Without Additive Homeopathic Therapy

Tumor Clinical Trial

Official title:

Evaluation of Quality of Life of Tumor Patients With and Without Additive Homeopathy.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00861432
• Other study ID #: 2341
• Status: Completed
• Phase: Phase 2
• First received: March 12, 2009
• Last updated: September 12, 2016
• Start date: December 2008
• Est. completion date: April 2011

Study information

• Verified date: September 2016
• Source: Medical University of Vienna
• Contact: n/a
• Is FDA regulated: No
• Health authority: Austria: Ethikkommission
• Study type: Interventional

Clinical Trial Summary

Tumor patients receiving conventional tumor therapies are included into this study. The patients are randomized into two groups receiving either additive homeopathic therapy or not. Two questionnaires referring to subjective feeling and life quality are filled out by the patients with each visit to the outpatients Department. One of them is the QLQC30 questionnaire of the EORTC. The results of the questionnaires of the two groups are compared.

Description:

Quality of life is an important issue for cancer patients, especially during the periods of chemotherapy and radiation. Preliminary results have revealed positive effects of add-on homeopathy on quality of life as well as subjective well-being. Patients are receiving classical homeopathy with administration of either globules and/or dilutions. With each appointment, patients complete two questionnaires.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 400
• Est. completion date: April 2011
• Est. primary completion date: July 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Tumor patients between 18 and 100 years old

Exclusion criteria: Patients younger than 18 years, patients having completed less than 3 questionnaires.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Tumor

Intervention

Other:
• additive homeopathic treatment
These patients receive additive homeopathic treatment

Locations

Country	Name	City	State
Austria	Med. Univ. Vienna, Dept. Internal Med. I	Vienna

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Difference with regard to subjective feeling and life quality with or without homeopathic treatment		3 months	Yes